SENTI

Serial Number 97006723
Registration 7502837
700

Registration Progress

Application Filed
Sep 1, 2021
Under Examination
Mar 7, 2023
Approved for Publication
Jan 10, 2023
Published for Opposition
Jan 10, 2023
Registered
Sep 10, 2024

Trademark Image

SENTI

Basic Information

Serial Number
97006723
Registration Number
7502837
Filing Date
September 1, 2021
Registration Date
September 10, 2024
Published for Opposition
January 10, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Sep 10, 2024
Registration
Registered
Classes
005

Rights Holder

Senti Biosciences, Inc.

03
Address
2 Corporate Drive, First Floor
South San Francisco, CA 94080

Ownership History

Senti Biosciences, Inc.

Original Applicant
03
South San Francisco, CA

Senti Biosciences, Inc.

Owner at Publication
03
South San Francisco, CA

Senti Biosciences, Inc.

Original Registrant
03
South San Francisco, CA

Legal Representation

Attorney
Nicole Kinsley, Esq.

USPTO Deadlines

Next Deadline
1877 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-09-10)
Due Date
September 10, 2030
Grace Period Ends
March 10, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

34 events
Date Code Type Description Documents
Sep 10, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Sep 10, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Aug 5, 2024 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Aug 5, 2024 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Jul 12, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jul 12, 2024 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Jun 3, 2024 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jun 3, 2024 IUAF S USE AMENDMENT FILED Loading...
Mar 7, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 6, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
Mar 6, 2024 EX2G S SOU EXTENSION 2 GRANTED Loading...
Mar 6, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 5, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 1, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 1, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
Sep 1, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
Jun 30, 2023 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Jun 30, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 30, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jun 30, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Mar 7, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 10, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 10, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 21, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 6, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 2, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 1, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 1, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 7, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 7, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 7, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 7, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 14, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 4, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Cells for medical or clinical use; genetic material for medical or clinical use; house mark for pharmaceutical products for human use, namely, pharmaceutical preparations for treating diseases through cell therapy and gene therapy
First Use Anywhere: May 1, 2024
First Use in Commerce: May 1, 2024

Additional Information

Translation
The English translation of "SENTI" in the mark is "CENTS".

Classification

International Classes
005